Pharma can target ultra-rare conditions — the next step is financing them

Date:
July 26, 2023
​
今すぐ登録

As science has enabled care for previously untreatable, ultra-rare conditions, health systems and governments are struggling with ways of financing research and development of these therapies. What are the solutions when the science has progressed, but the economics haven't?

Click here to find additional information and registration details.

トピック

Health Economics & Outcomes Research (HEOR)

今すぐ視聴する

関連コンテンツ

​
オンデマンド
November 5, 2026

Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk

Sponsor:
ICON
See more
​
オンデマンド
July 28, 2026

Filling the Gap: Integrating Patient-Generated Data into Real-World Evidence

Sponsor:
Veradigm
See more
​
今後の予定
November 5, 2026

Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk

Sponsor:
ICON
​
今後の予定
November 5, 2026

Filling the Gap: Integrating Patient-Generated Data into Real-World Evidence

Sponsor:
Veradigm
​
今後の予定
November 5, 2026

Closing Gaps in Care: Health Equity and the Inflation Reduction Act - A Cutting Edge Conversation

Sponsor:
The PPD clinical research business of Thermo Fisher Scientific Inc.
Panalgo, LLC
​
今後の予定
November 5, 2026

Network meta-analysis and its role in evidence-based decision-making

Sponsor:
ICON
​
今後の予定
November 5, 2026

Addressing Orphan and Rare Diseases - A Cutting Edge Conversation

Sponsor:
HealthLumen
ICON
​
今後の予定
November 5, 2026

Joint Clinical Assessment 2025: Pioneering Pathways for Oncology, Advanced Therapies & Rare Diseases

Sponsor:
ICON
​
今後の予定
November 5, 2026

RWE reality check: Routine patient health records and regulatory requirements

Sponsor:
Cardinal Health
​
今後の予定
November 5, 2026

"S" Stands for Systematic: Demystifying the Systematic Literature Review

Sponsor:
ICON
​
今後の予定
November 5, 2026

Survival Analysis for Immature Data: A Review of Techniques and Lessons Learned

Sponsor:
ICON
​
今後の予定
November 5, 2026

Market Access - Transforming BioTech Commercial Decisions?

​
今後の予定
November 5, 2026

The Scientific and Operational Elegance of Study Replication with Real-World EHR Data: A Vitiligo and Alopecia Example

Sponsor:
Panalgo, LLC
​
今後の予定
November 5, 2026

Insights from the 2024 Salary Survey Report by HealthEconomics.com

​
今後の予定
November 5, 2026

Integrated Evidence Generation Planning: Driving Successful Reimbursement and Life Cycle Management

Sponsor:
OPEN Health
​
今後の予定
November 5, 2026

Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches

Sponsor:
Carelon Research
​
今後の予定
November 5, 2026

Strategies to Optimize Commercialization of Oncology Treatments for Younger Adults

Sponsor:
ICON
​
今後の予定
November 5, 2026

Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters

Sponsor:
ICON
​
今後の予定
November 5, 2026

Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access

Sponsor:
PRECISIONheor
OPEN Health
PRMA Consulting
​
今後の予定
November 5, 2026

EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025

Sponsor:
OPEN Health
​
今後の予定
November 5, 2026

Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases

Sponsor:
Inspire
​
今後の予定
November 5, 2026

Pharma can target ultra-rare conditions — the next step is financing them

​
今後の予定
November 5, 2026

Advancing identity data management for digital engagement: How leading organizations are doing it

​
今後の予定
November 5, 2026

Keeping up with demands for healthcare outside of the hospital: Critical ways tech supports the distributed care model

​
今後の予定
November 5, 2026

Driving value from healthcare data: How integrated cloud-based data is foundational to drive enterprise change

​
今後の予定
November 5, 2026

Closing the gaps of getting data to make decisions

​
今後の予定
November 5, 2026

How Digital Health Can Empower Cancer Patients

​
今後の予定
November 5, 2026

Clinical Trial Innovation: How Healthcare Technology is Evolving

​
今後の予定
November 5, 2026

Connected communities: Advancing population health through data and emerging technology

​
今後の予定
November 5, 2026

Certified Corporate Wellness Specialist(CCWS): Is It For Me?

​
今後の予定
November 5, 2026

The reimagined hospital: How health systems are keeping up with new tech

​
今後の予定
November 5, 2026

L7|LIVE SF - Tuesday, June 13th, 2023

​
今後の予定
November 5, 2026

Transforming Healthcare Using Big Data and Remote Monitoring

​
今後の予定
November 5, 2026

Synthesise RWE and AI. Transform patient-driven healthcare

​
今後の予定
November 5, 2026

Endpoints at #DIA23

​
今後の予定
November 5, 2026

From Challenges to Opportunities: Navigating the EU MDR as a Medical Device Manufacturer

​
今後の予定
November 5, 2026

Ushering in the new era of payvider integration

​
今後の予定
November 5, 2026

Partnering with NHS in a crisis: The role for industry

​
今後の予定
November 5, 2026

Unlock the Power of Data Review & Collaboration: Maximizing Trial Success

​
今後の予定
November 5, 2026

HTA Implementation in the MEA Region - an Overview from WHO and Country Updates

​
今後の予定
November 5, 2026

Improving Treatment Access & Outcomes by Integrating Social Determinants of Health Data with Real-World Evidence

​
今後の予定
November 5, 2026

How to Supercharge Real World Evidence Generation in Phase IV Trials

​
今後の予定
November 5, 2026

Webcast: Taking the Complexity Out of Leveraging Health Plan Price Transparency Data

​
今後の予定
November 5, 2026

FDA Patient-Focused Drug Development (PFDD) Guidance

​
今後の予定
November 5, 2026

Creating Digital Biomarkers with Real-World and Existing Data by Xtalks

​
今後の予定
November 5, 2026

Beyond the payment variance report: How to resolve common, costly underpayment issues

​
今後の予定
November 5, 2026

Webcast: Strategies to Simplify Insurance Discovery

​
今後の予定
November 5, 2026

Looking Beyond Survival Data: Understanding the Value of Non-OS Endpoints in Oncology Reimbursement Decision-Making

​
今後の予定
November 5, 2026

Measuring the intangible- what is the true value of a "patient centric" initiative

​
今後の予定
November 5, 2026

Champion a seamless end-to-end insight generation process

​
今後の予定
November 5, 2026

Different HTA Perspectives on Reliably Estimating Treatment Effects

​
今後の予定
November 5, 2026

The Biotech landscape: Market trends, priorities, predictions, and pathways to FDA approval

​
今後の予定
November 5, 2026

Fit for Local Context? Establishing or Improving Deliberative Processes for HTA

​
今後の予定
November 5, 2026

Evidence Matters 2022

​
今後の予定
November 5, 2026

US Drug Pricing Reform: Potential impact on Pharma HEOR Evidence Generation - September 8th

​
今後の予定
November 5, 2026

When the Barrier to a Breakthrough Drug is You Can't Make It - September 28th

​
今後の予定
November 5, 2026

Cell & Gene Day 2022 | Virtual Event | August 24th

​
今後の予定
November 5, 2026

Biology's modern LIMS for labs of the future - August 17 | 12:00 pm - 1:00 pm EDT

​
今後の予定
November 5, 2026

Confronting care inequities in hospital medicine - August 18th, 2022

​
今後の予定
November 5, 2026

Pain R&D: Plenty of pain to go around, but who's making gains?

​
今後の予定
November 5, 2026

AI and Machine Learning Technologies: The New Normal of the Pharmaceutical Industry - July 27th

​
今後の予定
November 5, 2026

Digital Transformation to Support Operational, Therapeutic and Clinical Decision Making

​
今後の予定
November 5, 2026

Selecting Rapid Review Methods for Health Technology Assessment

​
今後の予定
November 5, 2026

Predicting Payer Uptake with Precision

​
今後の予定
November 5, 2026

It's Not FAIR! Improving Data Publishing Practices in Research-Interoperability

​
今後の予定
November 5, 2026

Exploring Best Practices and Innovation in New Registry Handbook: Part 2 - Understanding Quality

​
今後の予定
November 5, 2026

Rise of the Robots 2.0: Real Talk About Artificial Intelligence In Systematic Reviews

​
今後の予定
November 5, 2026

Informational Webinar & Alumni Panel: Online MS Degree, Pharm Outcomes & Policy

​
今後の予定
November 5, 2026

Patient-Centric RWE Research & Remote Monitored Care: Learnings from a support program leveraging telehealth & connected devices

​
今後の予定
November 5, 2026

Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation

Sponsor:
Evidera, part of PPD
​
今後の予定
November 5, 2026

Minimizing the Impact of Cross-Cultural Differences in COA Translations

Sponsor:
ICON
​
今後の予定
November 5, 2026

What Every Researcher Needs to Know About Using Medicare Data for Real World Evidence

Sponsor:
PHAR
​
今後の予定
November 5, 2026

Medicare Part D: Price Negotiation Panel Discussion

Sponsor:
ICON
​
今後の予定
November 5, 2026

Finding Value in Linking Real-World Data with Social Determinants of Health

Sponsor:
Magnolia Market Access
​
今後の予定
November 5, 2026

Health Economic and Outcome Research (HEOR) for Medical Technologies for the US Healthcare Systems

Sponsor:
Alira Health
​
今後の予定
November 5, 2026

Streamlining Health Technology Assessments by Automating Literature Reviews

Sponsor:
DistillerSR
​
今後の予定
November 5, 2026

Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access

Sponsor:
Genesis Research Group
​
今後の予定
November 5, 2026

Achieving Consensus When Everyone is an Expert, but No One Agrees

Sponsor:
PHAR
​
今後の予定
November 5, 2026

Making HEOR More Accessible to Patients

Sponsor:
OPEN Health
​
今後の予定
November 5, 2026

An Introduction to Infectious Disease Modeling

Sponsor:
ICON
​
今後の予定
November 5, 2026

Evidence Synthesis for Sparse Evidence Base, Heterogeneous Studies, and Disconnected Networks

Sponsor:
ICON
​
今後の予定
November 5, 2026

Optimize Your Value Story Through Integrated Evidence Generation - From Bench to Patient

Sponsor:
Syneos Health
​
今後の予定
November 5, 2026

Understanding Health Care Decision Maker Preferences for Optimized Engagement

Sponsor:
ICON
​
今後の予定
November 5, 2026

Data Integrity in Decentralized Clinical Trials (DCTs)

Sponsor:
Actu-Real
​
今後の予定
November 5, 2026

How Cerner Enviza Uses Clinical Data to Drive RWE Decisions

Sponsor:
Cerner Enviza
​
今後の予定
November 5, 2026

Optimizing Real-World Evidence for Maternal and Neonatal Outcomes

Sponsor:
HealthCore, Inc.
​
今後の予定
November 5, 2026

How Literature Review Automation and Efficient Processes Streamline RWE HEOR Studies

Sponsor:
DistillerSR
​
今後の予定
November 5, 2026

Using External Control Arm Studies in HTA Submissions: An Alternative, When RCTs are not Feasible

Sponsor:
ICON
​
今後の予定
November 5, 2026

Can Literature Review Automation Improve Healthcare Cost-Effectiveness Analysis and Budget Impact Modeling Outcomes?

Sponsor:
PHAR
​
今後の予定
November 5, 2026

Value-Based Agreements - Are We Going to See More or Less of Them?

Sponsor:
Actu-Real
​
今後の予定
November 5, 2026

Respiration in Anesthetized Mice: Evidence-Based Recommendations for Improved Monitoring & Supportive Care

Sponsor:
Kent Scientific Corporation

関連コンテンツ

​
デモを見る

現代のライフサイエンスを支えるデジタル基盤

プロバイダー、ワークフロー、承認、コンプライアンス、データ、支出を一元管理できるインテリジェントなプラットフォームをご紹介します。複雑なプロジェクトをより迅速に、高い可視性と管理体制のもとで推進することが可能です。

​
パーソナライズされたデモをリクエストする